Market revenue in 2023 | USD 1,907.6 million |
Market revenue in 2030 | USD 6,512.1 million |
Growth rate | 19.2% (CAGR from 2023 to 2030) |
Largest segment | Injectables |
Fastest growing segment | Injectables |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Injectables, Skin Rejuvenation |
Key market players worldwide | Hologic Inc, AbbVie Inc, Galderma Group AG Registered Shares, Alma Lasers Ltd, UltraShape Ltd. (Syneron Medical), Johnson & Johnson, Merz Pharma, Lumenis, Bausch Health Companies Inc, Cutera Inc, Revance Therapeutics Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non-invasive aesthetic treatment market will help companies and investors design strategic landscapes.
Injectables was the largest segment with a revenue share of 62.87% in 2023. Horizon Databook has segmented the India non-invasive aesthetic treatment market based on injectables, skin rejuvenation covering the revenue growth of each sub-segment from 2018 to 2030.
India’s healthcare industry is the fastest-growing sector today and is currently worth USD 0.31 billion. India is expected to dominate the global market in the coming years, but, currently, it is the third largest market in the APAC region after China and Japan.
Key market drivers include increasing affordability of aesthetic procedures along with growing disposable income & awareness about these procedures. According to Sanjay Bhutani, MD India and SAARC for Bausch & Lomb Eyecare (India), India ranks fourth with respect to total number of cosmetic procedures being carried out in APAC.
Moreover, according to IBEF, the cost of aesthetic procedures in India is about one-tenth of that in the U.S. or Western Europe, and the country ranks 145th among 195 countries in terms of quality and accessibility of healthcare. India is also cost competitive as compared to its Asian peers and western countries, leading to a noticeable boom in medical tourism sector.
Horizon Databook provides a detailed overview of country-level data and insights on the India non-invasive aesthetic treatment market , including forecasts for subscribers. This country databook contains high-level insights into India non-invasive aesthetic treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account